chr8-120455439-A-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_022045.5(MTBP):c.489A>T(p.Arg163Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000627 in 1,593,716 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00032 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000036 ( 0 hom. )
Consequence
MTBP
NM_022045.5 missense
NM_022045.5 missense
Scores
4
7
8
Clinical Significance
Conservation
PhyloP100: 2.96
Genes affected
MTBP (HGNC:7417): (MDM2 binding protein) This gene encodes a protein that interacts with the oncoprotein mouse double minute 2. The encoded protein regulates progression through the cell cycle and may be involved in tumor formation. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.27411664).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTBP | NM_022045.5 | c.489A>T | p.Arg163Ser | missense_variant | 6/22 | ENST00000305949.6 | NP_071328.2 | |
MTBP | XM_011516962.3 | c.489A>T | p.Arg163Ser | missense_variant | 6/18 | XP_011515264.1 | ||
MTBP | XM_011516963.3 | c.489A>T | p.Arg163Ser | missense_variant | 6/14 | XP_011515265.1 | ||
MTBP | XR_928318.3 | n.541A>T | non_coding_transcript_exon_variant | 6/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTBP | ENST00000305949.6 | c.489A>T | p.Arg163Ser | missense_variant | 6/22 | 1 | NM_022045.5 | ENSP00000303398 | P1 | |
MTBP | ENST00000523373.5 | c.489A>T | p.Arg163Ser | missense_variant, NMD_transcript_variant | 6/11 | 5 | ENSP00000430771 |
Frequencies
GnomAD3 genomes AF: 0.000316 AC: 48AN: 151994Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
48
AN:
151994
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000847 AC: 20AN: 236154Hom.: 0 AF XY: 0.0000469 AC XY: 6AN XY: 128014
GnomAD3 exomes
AF:
AC:
20
AN:
236154
Hom.:
AF XY:
AC XY:
6
AN XY:
128014
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000361 AC: 52AN: 1441604Hom.: 0 Cov.: 27 AF XY: 0.0000377 AC XY: 27AN XY: 717118
GnomAD4 exome
AF:
AC:
52
AN:
1441604
Hom.:
Cov.:
27
AF XY:
AC XY:
27
AN XY:
717118
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000316 AC: 48AN: 152112Hom.: 0 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74356
GnomAD4 genome
AF:
AC:
48
AN:
152112
Hom.:
Cov.:
32
AF XY:
AC XY:
30
AN XY:
74356
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
5
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
12
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 13, 2024 | The c.489A>T (p.R163S) alteration is located in exon 6 (coding exon 6) of the MTBP gene. This alteration results from a A to T substitution at nucleotide position 489, causing the arginine (R) at amino acid position 163 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
D
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Pathogenic
Sift
Benign
T
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Gain of disorder (P = 0.0569);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at